Xellar Biosystems: Series A

Beijing startup developing non-invasive wearable brain-computer interfaces that combine brain-signal detection, decoding and neural modulation.

Biotechnology company discovering and developing antibody therapies for diseases with significant unmet need.

Yizhu Technology designs compute-in-memory chips for AI inference and post-training workloads.

Clinical-stage drug developer using AI to select therapeutic assets and guide oncology trials.